Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 467 publications.

Ramamohan V, Mladsi D, Ronquest N, Boklage S. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among CHF patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S53.

Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Int J Dermatol. 2015 Oct;54(10):e442-5. doi: 10.1111/ijd.12921

Martin N, Germano R, Hartley L, Adler AJ, Rees K. Nut consumption for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2015 Sep 28;(9):CD011583. doi: 10.1002/14651858.CD011583.pub2

Hartley L, Clar C, Ghannam O, Flowers N, Stranges S, Rees K. Vitamin K for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2015 Sep 21;(9):CD011148. doi: 10.1002/14651858.CD011148.

Masclee GMC, Valkoff VE, Straatman H, Herings R, Garbe E, Schink T, Kollhorst B, Arfe A, Lucchi S, Villa M, Castellsague J, Perez-Gutthann S, Varas-Lorenzo C, Schade R, Schuemie M, Vergouwe Y, Steyerberg E, Sturkenboom M, Romio S. Individualized NSAID prescribing based on gastrointestinal and cardiovascular risks: a decision model in the SOS project. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA. [abstract] Pharmacoepidemiol Drug Saf. 2015 Sep; 24(S1):36-7. doi: 10.1002/pds.3838

Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Cochrane Database Syst Rev. 2015 Aug 4;(8):CD011163. doi: 10.1002/14651858.CD011163.pub2

Masclee GMC, Straatman H, Herings R, Garbe E, Schink T, Kollhurst B, Arfe A, Lucchi S, Villa M, Castellsague J, Perez-Gutthann S, Varas-Lorenzo C, Romio S, Schade R, Schuemie MJ, Valkoff VE, Sturkenboom MCJM. Risk of acute myocardial infarction during use of individual NSAIDs: a nested case-control study in the SOS project. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Hartley L, Lee MS, Kwong JSW, Flowers N, Todkill D, Ernst E, Rees K. Qigong for the primary prevention of cardiovascular disease (Review). Cochrane Database Syst Rev. 2015 Jun 11;(6):CD010390.

Korsnes JS, Davis KL, Ariely R, Bell C, Mitra D. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Pharm. 2015 Jun;21(6):443-50.

Hansen MK, Gammelager H, Jacobsen CJ, Hjortdal VE, Layton JB, Rasmussen BS, Andreasen JJ, Johnsen SP, Christiansen CF. Acute kidney injury and long-term risk of cardiovascular events after cardiac surgery: a population-based cohort study. J Cardiothorac Vasc Anesth. 2015 Jun;29(3):617-25. doi: 10.1053/j.jvca.2014.08.020

Kubesch N, de Nazelle A, Guerra S, Westerdahl D, Martinez D, Bouso L, Carrasco-Turigas G, Hoffmann B, Nieuwenhuijsen MJ. Arterial blood pressure responses to short-term exposure to low and high traffic-related air pollution with and without moderate physical activity. Environ Int. 2015 May;22(5):548-57. doi: 10.1177/2047487314555602

Hartley L, Girling A, Bowater R, Lilford R. A multistudy analysis investigating systematic differences in cardiovascular trial results between Europe and Asia. J Epidemiol Community Health. 2015 Apr;69(4):397-404. doi: 10.1136/jech-2013-203646

Sherrill B, Fernandez MM, Wang J, Xin Y, Kwong WJ, Sherif BN, Hogue SL. Network meta-analysis of relative efficacy and safety of edoxaban versus other novel oral anticoagulants (NOACs) among atrial fibrillation patients with CHADS2 score greater than or equal to 2. Poster presented at the American College of Cardiology; March 16, 2015. San Diego, CA.

Boardman HM, Hartley L, Eisinga A, Main C, Roque i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015 Mar 10;3:CD002229. doi: 10.1002/14651858.CD002229

Brennan VK, Mauskopf JA, Colosia AD, Copley-Merriman K, Hass B, Palencia R. Utility estimates for patients with type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):111-23.

Brogan AP, Hogue SL, Mordin MM, Kwong J. United States decision maker perceptions of data from observational studies and other health economics and outcomes research. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015; 18:A1-A333.

Hartley L, May MD, Rees K. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2015;(1):CD011472. doi: 10.1002/14651858.CD011472.pub2

Bowater RJ, Hartley LC, Lilford RJ. Are cardiovascular trial results systematically different between North America and Europe? A study based on intra-meta-analysis comparisons. Arch Cardiovasc Dis. 2015 Jan;108(1):23-38. doi: 10.1016/j.acvd.2014.03.005

Hartley L, Mavrodaris A, Flowers N, Ernst E, Rees K. Transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014 Dec 1;12:CD010359. doi: 10.1002/14651858.CD010359

Barrett AM, Harris NI, DeMuro-Mercon CJ, Phatak H. Literature review of patient-reported outcome measures assessing anticoagulant therapy. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.

Mitchell S, Roso S, Samuel M, Woods MS, Pladevall-Vila M. Targeted literature review of unmet need in the hyperlipidaemia population with high risk of cardiovascular disease. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Arana A, Johannes C, Varas-Lorenzo C, Rothman KJ, McQuay LJ, Yang Q, Fife D. Assessment of daily dose of domperidone in the clinical practice research datalink (CPRD) using multiple information sources. Poster presented at the 30th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):329.

Arana A, Johannes CB, Varas-Lorenzo C, Rothman KJ, McQuay LJ, Yang Q, Fife D. Risk of out-of-hospital sudden cardiac death with use of domperidone, prototon pump inhibitors, and metoclopramide. Poster presented at the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):189.

Bae JP, Candrilli SD, Fortenberry J, Meyers JL, Jakubowski JA, Drenning D. Point-of-care platelet reactivity determination with VerifyNow-P2Y12® following administration of clopidogrel or prasugrel: data from a real-world, clinical-care inpatient setting. Hospital Practice. 2014 Oct;42(4):7-15. doi: 10.3810/hp.2014.10.1139

Heaton B, Applebaum KM, Rothman KJ, Brooks DR, Heeren T, Dietrich T, Garcia RI. The influence of prevalent cohort bias in the association between periodontal disease progression and incident coronary heart disease. Ann Epidemiol. 2014 Oct;24(10):741-6. doi: 10.1016/j.annepidem.2014.07.006

Afonso ASM, Schmiedl S, Becker C, Primatesta P, Plana E, Souverin PC, Korevaar JC, Hasford J, Reynolds R, de Groot MCH, Schlienger RG, Klungel OH, Rottenkolber M. Association between inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction: a methodological comparison of two databases. Poster presented at the 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; October 2014. Taipei, China. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):390-1.

Rottenkolber M, Rottenkolber D, Fischer R, Ibáñez L, Fortuny J, Ballarin E, Sabaté M, Ferrer P, Thürmann P, Hasford J, Schmiedl S. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients. Respir Med. 2014 Aug;108(8):1075-90.

Brennan VK, Colosia AD, Copley-Merriman K, Mauskopf J, Haas B, Psalencia R. Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. J Med Econ. 2014 Jul;17(7):469-80. doi: 10.3111/13696998.2014.915847

Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther. 2014 Jun;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012.

Ariely R, Korsnes JS, Mitra D, Davis KL, Bell C. Major adverse cardiovascular events in U.S. acute coronary syndrome patients in the United States. Poster presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions; June 2014.

Maclean EN, Stone IS, Ceelen F, Garcia-Albeniz X, Sommer WH, Petersen SE. Reporting standards in cardiac MRI, CT, and SPECT diagnostic accuracy studies: analysis of the impact of STARD criteria. Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):691-700. doi: 10.1093/ehjci/jet277

Hartley L, Dyakova M, Holmes J, Clarke A, Lee MS, Ernst E, Rees K. Yoga for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014 May 13;5:CD010072.

Hartley L, Flowers N, Lee MS, Ernst E, Rees K. Tai chi for primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014 Apr 9;4:CD010366. doi: 10.1002/14651858.CD010366

Al-Khudairy L, Hartley L, Clar C, Flowers N, Hooper L, Rees K. Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014 Apr;11:CD011094. doi: 10.1002/14651858.CD011094.pub2

Huisman MV, Lip GY, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Teutsch C, Zint K, Ackermann D, Clemens A, Bartels DB. Design and rationale of global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006

Pletcher MJ, Pignone M, Earnshaw SR, McDade CL, Phillips KA, Auer R, Zablotska L, Greenland P. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2014 Mar 1;7(2):276-84. doi: 10.1161/CIRCOUTCOMES.113.000799

Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043

Stalhammar J, Stern L, Linder R, Sherman S, Parikh RC, Ariely R, Deschaseaux C, Wikstrom G. The burden of preserved ejection fraction heart failure in a real-world Swedish patient population. J Med Econ. 2014 Jan 25;17(1):43-51. doi: 10.3111/13696998.2013.848808

Flowers N, Hartley L, Todkill D, Stranges S, Rees K. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;12:CD010405. doi: 10.1002/14651858.CD010405

Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin JA. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives. Curr Med Res Opin. 2014;30(9):1733-41.

Chopra I, Kamal KM, Candrilli SD, Kanyongo G. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia. Postgrad Med. 2014 Jan;126(1):66-77. doi: 10.3810/pgm.2014.01.2726.

Hansen MK, Gammelager H, Mikkelsen MM, Hjortdal VE, Layton JB, Johnsen SP, Christiansen CF. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care. 2013 Dec 12;17(6):R292. doi: 10.1186/cc13158

Le Moine JG, Katumba KR, Launois R. Structural validation of the chronic venous insufficiency questionnaire-14 (CIVIQ-14): a confirmatory factor analysis. Poster presented at the International Society for Pharmacoeconomics and Outcome Research 16th Annual European Congress; November 2, 2013. Dublin, Ireland.

Wolowacz S, Brockbank J, Sunderland TJ, Gonschior AK. Cost-effectiveness of dabigatran etexilate for the secondary prevention of recurrent deep vein thrombosis and pulmonary embolism in the United Kingdom. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A526.

Parikh R, Franzini L. Health care expenditure among hypertensive diabetics and its association with quality of care. Poster presented at the 141st American Public Health Association Annual Meeting; November 2013. Boston, MA.

Twiss J, McKenna S, Graham JE, Swetz KM, Sloan J, Gomberg-Matiland M. Assessing measurement equivalence of different forms of administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) using Rasch analysis. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A606. doi: 10.1016/j.jval.2013.08.1731

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Margulis A, Pladevall M, Miguel G, Romio S, Sturkenboom M, Perez-Gutthann S. Cardiovascular risk with glitazones and metformin: results from a systematic review of observational studies. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2013. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct 7; 22(S1):68.

Layton JB, Brookhart MA, Jonsson Funk M, Simpson, Jr RJ, Pate V, Sturmer T, Kshirsagar AV. Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1061-70. doi: 10.1002/pds.3500

Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013 Sep 17;6:327-38.

Bowater R, Hartley L, Lilford R. Are cardiovascular trial results systematically different between Europe and North America? A multi-study analysis. Poster presented at the Society for Social Medicine conference at the Brighton and Sussex Medical School; September 11, 2013. Brighton, United Kingdom.